Proactive Investors - Run By Investors For Investors

Liberty Health Sciences opens first dispensary in South Florida

The new dispensary offers medical marijuana products and is located at 6827 Bird Road in Miami
Florida
Liberty is also boosting production capacity at its Liberty 360 plant in Gainesville, Florida

The Canadian cannabis company Liberty Health Sciences Inc (CSE:LHS) (OTCQX:LHSIF) on Tuesday opened its first South Florida dispensary in the center of Miami.

The new dispensary offers medical marijuana products and educational services and is located at 6827 Bird Road in Miami. It will be open from 10 a.m. to 7 p.m. on weekdays and will have slightly modified hours on weekends.

In addition to the Miami location, Liberty plans to open three more dispensaries in Florida this month and there will be more to come next year, pending approval by Florida’s Department of Health.

READ: Liberty Health Sciences signs deal to use AI-driven analytics to boost cannabis production

“Liberty remains committed to ensuring that its premium quality medical marijuana products and educational services are accessible to the more than 2.7 million people who call South Florida home,” said Liberty CEO George Scorsis in a statement.

To keep up with demand as it adds more dispensaries, Liberty is boosting production capacity at its Liberty 360 plant in Gainesville, Florida. The facility currently boasts 20,000 square feet of cultivation space and its next phase of 80,000 square feet is set to be completed by February.

Toronto-based Liberty has also improved its research and development capabilities at the Liberty 360 operation and continues to develop different formats and varieties of cannabis.

Liberty Health shares slipped by 1% to C$0.94 in Tuesday’s morning trading session.

Contact Ellen Kelleher at [email protected]

View full LHS profile View Profile

Liberty Health Sciences Timeline

Related Articles

Oncoprex
October 17 2018
The biotech was founded by an investment group led by scientists and driven by a no-nonsense CEO whose stake is more than just business as usual
Cancer cells
June 27 2018
The Nottingham-based privately-owned company has made an impressive fist of developing the OMIS (Opto-magnetic Imaging Spectroscopy) cancer detection system
scientist in lab
December 20 2018
Data from Midatech's MTD201 drug has validated the company's Q-Sphera sustained release technology, and other, bigger players are starting to sit up and take note
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use